- Home
- UBX vs DALN Comparison
UBX vs DALN Comparison
Compare UBX & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- DALN
- Stock Information
- Founded
- UBX 2009
- DALN 1954
- Country
- UBX United States
- DALN United States
- Employees
- UBX N/A
- DALN N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- DALN Newspapers/Magazines
- Sector
- UBX Health Care
- DALN Consumer Discretionary
- Exchange
- UBX Nasdaq
- DALN Nasdaq
- Market Cap
- UBX 24.6M
- DALN 24.6M
- IPO Year
- UBX 2018
- DALN 2008
- Fundamental
- Price
- UBX $1.00
- DALN $4.87
- Analyst Decision
- UBX Strong Buy
- DALN
- Analyst Count
- UBX 1
- DALN 0
- Target Price
- UBX $8.00
- DALN N/A
- AVG Volume (30 Days)
- UBX 82.0K
- DALN 95.3K
- Earning Date
- UBX 11-04-2024
- DALN 11-12-2024
- Dividend Yield
- UBX N/A
- DALN 3.13%
- EPS Growth
- UBX N/A
- DALN N/A
- EPS
- UBX N/A
- DALN N/A
- Revenue
- UBX N/A
- DALN $128,286,000.00
- Revenue This Year
- UBX N/A
- DALN N/A
- Revenue Next Year
- UBX $33.62
- DALN N/A
- P/E Ratio
- UBX N/A
- DALN N/A
- Revenue Growth
- UBX N/A
- DALN N/A
- 52 Week Low
- UBX $1.00
- DALN $2.98
- 52 Week High
- UBX $2.02
- DALN $6.47
- Technical
- Relative Strength Index (RSI)
- UBX 28.85
- DALN 46.65
- Support Level
- UBX $1.10
- DALN $4.78
- Resistance Level
- UBX $1.23
- DALN $4.74
- Average True Range (ATR)
- UBX 0.06
- DALN 0.39
- MACD
- UBX -0.01
- DALN 0.01
- Stochastic Oscillator
- UBX 0.00
- DALN 49.52
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.